Abzena to raise $30M to buy another U.S. contract drug developer

Abzena, a U.K.-based pharma services company, appears to be on an acquisition tear of late, saying it plans to buy a second U.S.-based company in as many months.

Novo Nordisk says all its manufacturing plants will run on renewable electricity by 2020

Novo Nordisk, the Danish maker of insulin, said all of its global manufacturing facilities will run on electricity generated from renewable sources by 2020.

Synerlab buys contract manufacturing developer Alcala Farma for undisclosed price

Synerlab, a French pharmaceutical manufacturer, has purchased Spain-based contract development and manufacturing company Alcala Farma for an undisclosed amount.

Some production resumes at Strides Shasun facility following fire that killed one

Strides Shasun has resumed limited production at its Cuddalore API plant in India following a fire last week that killed one worker.

South Africa's Ascendis picks up manufacturing facility in $24.6M deal for Akacia

South Africa-based Ascendis Health has acquired a 23,000-square-foot manufacturing facility as part of its $24.6 million deal for the pharmaceutical business of Akacia Healthcare.

New York man convicted of selling counterfeit and illegal drugs in U.S.

William Scully, one of two owners of Medical Device King based in New York, was convicted on charges that he sold more than $17 million worth of fake or unapproved drugs that were manufactured overseas.

A Pfizer-Allergan marriage could prove hard on their manufacturing networks

Pfizer and Allergan are reportedly close to announcing a merger that would turn the two into the largest of the Big Pharma companies, Bloomberg has reported. They also would have the largest manufacturing network with possibly more than 100 production facilities. But Pfizer's acquisition record suggests that number would shrink significantly postmerger as it looked for ways to cut costs to pay for the massive deal.

With pharma cargo theft on the rise, Thanksgiving can be a risky holiday

While next week's long Thanksgiving holiday will be enjoyed by most workers in the U.S., logistics security firm FreightWatch International reminds companies that thieves use the added time to target warehouses and over-the-road trucks.

Drug distributor recalls anxiety drug after wrong med found in a bottle

Connecticut-based Breckenridge Pharmaceutical is recalling a lot of duloxetine after a single tablet of a stomach-upset drug was found in a bottle of the generic anxiety drug.

Shortages, shifts in sterile injectable market lead some prices to soar

Last month, four U.S. senators asked the FTC to investigate "possible illegal collusion" by saline solution manufacturers to determine whether they had been unfairly cashing in on a two-year shortage. But saline is only one of hundreds of hospital generic injectable drugs whose prices have soared in the last 8 years, And given the current state of affairs in the business, it is a situation unlikely to change.

Merck KGaA JV set to start producing drugs in remote Algerian village

Germany's Merck KGaA has for some years been taking steps to cash in on the growing population in emerging markets of people needing treatment for diabetes and associated conditions, sometimes building plants to make its diabetes treatments locally. Working through a joint venture, a plant is starting production in North Africa.

Hikma says FDA has closed out warning letter for EU injectables plant

Just over a year ago, a Hikma sterile injectables plant in Portugal was grilled in a warning letter for a variety of failings, some that the FDA said it had been warned about before. But Jordan-based Hikma said today that the FDA has indicated those problems are behind it.

Baxalta Singapore plant gets FDA OK to produce Advate hemophilia product

The hemophilia A treatment Advate is the cornerstone to the future of Baxalta, the company that was created when Baxter International spun off its drug operations in July. Now the newbie will be able to produce more of the product at a plant in Singapore it opened just last year.

Valeant adds recall to long list of problems

Add to Valeant Pharmaceuticals' growing list of problems a manufacturing mess-up that is leading to a recall of a cholesterol fighter.

Top Novartis exec in India says two plants warned by FDA completing remediation

Novartis India Managing Director Ranjit Shahani told India's PTI that the drugmaker expects upgrades at two Sandoz plants that were issued a warning letter by the FDA to soon be back to full production.

Regulator halts Catalent production at French plant where product sabotage suspected

Catalent, at the request of France's top pharma regulator, ANSM, halted production at a softgel plant on Friday after it reported to them that it had twice found "out-of-place" capsules in batches and suspected tampering.

Four Roche plants go up for sale in move to more high-potency, targeted drugs

Roche will close four plants around the world and lay off 1,200 people as it moves to new technology for manufacturing small molecule drugs. It says it will build a late-stage technical development and launch facility in Switzerland for targeted, high-potency drugs.

Endo, Patheon sued over unplanned pregnancies tied to contraceptive mishap

Four years ago, a unit of Endo Health Solutions recalled 3.2 million blister packs of birth control pills after discovering the pills may have been packaged in the wrong order. Now legal problems tied to the mess-up are swelling for Endo Health Solutions and contractor Patheon as more than 100 women have taken to the courts, saying they got pregnant as a result and want some child support.

CMO Formex and CRO BioDuro merge operations

San Diego-based contract manufacturer Formex has merged with China-based BioDuro. The merged groups will operate under the BioDuro name out of San Diego.

Cellular Biomedicine adds facility in China that will help with CAR-T processing

Cellular Biomedicine, a biotech working in the hot new area of treating cancer by creating CAR-T cells, has opened another facility in China.